Biocon Biologics Board Approves $150 Million Capital Injection From Goldman Sachs In Exchange For Optionally Convertible Debentures
Biocon Ltd. on the 7th of November announced that the Board of its subsidiary Biocon Biologics Ltd (Biocon Biologics) has approved a ₹ 1,125 crore ( $ 150 million) capital…